Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Aytu Biopharma (AYTU) Current Taxes: 2020-2021

Aytu Biopharma's Current Taxes was N/A to $182,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $182,000, marking a year-over-year change of. This contributed to the annual value of $175,000 for FY2020, which is N/A change from last year.
Aytu Biopharma's Current Taxes amounted to $182,000 in Q1 2021, which was up 4.00% from $175,000 recorded in Q2 2020.
Aytu Biopharma's 5-year Current Taxes high stood at $182,000 for Q1 2021, and its period low was $175,000 during Q2 2020.
Over the past 2 years, Aytu Biopharma's median Current Taxes value was $178,500 (recorded in 2020), while the average stood at $178,500.